With a long cycle of repeated Multiple Sclerosis (MS) drugs failure, have scientists finally found a treatment that suppresses the disease indefinitely? A press release by the NIH (National Institute of Health) expanded on the opportunity stem cell research has presented for MS patients. The NIAID (National Institute of Allergy and Infectious Diseases), a proponent of the NIH, played an integral role in clinical studies. The research included an advanced trial involving blood-forming stem cell transplantation. The final phase of the five-year long study appeared in the AAN (American Academy of Neurology) medical journal on Feb. 1. Researchers had submitted a progress report two years earlier.
Autoimmune diseases are of a complex nature which makes treatment discovery a challenging endeavor. MS, in particular, has had its share of challenges that neurologists are continuously exploring in greater depth. During this clinical study scientists explored HDIT (High-dose Immunosuppressive Therapy) and HCT (Hematopoietic Cell Transplant) react to MS. Of all participants, 69 percent manifested no signs of MS symptoms, developing brain lesions or progressing disability. With HDIT/HCT treatment being administered only once, subjects have shown impressive resistance and extended remission.
This breakthrough has many MS patients feeling hopeful about treatment. As scientists continue their research to expand on this new finding, neurologists like Dr. Shiva Gopal Vasishta are an asset to patients needing education on the procedure. He’s an expert neurology and psychiatry physician operating of New Jersey. Dr. Shiva Gopal Vasishta caters to both English and Spanish-speaking patients. He’s among the 34 resident specialists serving Kennedy University Hospital.
As an elite neurologist, Dr. Shiva Gopal Vasishta is a senior with over three decades serving the medical community. With his operating license, he also received a medical degree from India’s ivy league school, Government Medical College back in 1979. Additionally, he’s a first-class resident neurologist at New Jersey’s Eastern Neurodiagnostic Associates.